Scancell Holdings plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SCLP.L | ATORX.ST | HURA | CHRS | IMRX | APLM | |
|---|---|---|---|---|---|---|
| Market cap | 122.37M | 38.54M | 132.87M | 157.59M | 241.97M | 62.94M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -46.7 | -0.1 | -3.4 | -1.6 | -3.0 | -33.2 |
| Price/book | -4.8 | 2.2 | 7.3 | 2.6 | 1.3 | -14.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −2.62% | −99.57% | −21.78% | −40.48% | −30.28% | −24.45% |
| Today | −3.01% | −6.90% | +18.47% | +2.00% | +0.27% | −2.07% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SCLP.L news ›REG - Scancell Holdings - Result of General Meeting
(“Scancell”, the “Company” or the “Group”) Result of General Meeting Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, announces that all resolutions proposed at the…
What do Scancell’s fresh results reveal about its next development stage (LSE:SCLP)?
Why is Sizewell C opening a new chapter for Hargreaves (LSE:HSP)? Why has Caledonia reset the outlook for Blanket (LSE:CMCL)? What is driving DF Capital’s next lending chapter (LSE:DFCH)? The preliminary financial information is unaudited,…
Scancell, Eco Buildings, ATOME, Caledonia Mining, Oxford Metrics - Small Cap Snapshot
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) is pressing ahead with a Nasdaq listing via its merger with Neuphoria. Shareholders vote on 20 October, with around $75 million of financing expected. Read more Eco Buildings Group PLC…
RNS Hotlist October 9: Roundhouse AI, Ajax, Seraphim Space Investment Trust, ECR Minerals, Mendell Helium, Georgina Energy, Amigo Resources, Scancell Holdings
Comment: The goal of RHAI is to become the Bloomberg of its chosen area, autonomous-agent activity. This is a punchy goal for a significant addressable market: $15tln. Ideally, it has the early, listed company advantage, and the expertise…
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans to list on the Nasdaq stock exchange following an all-share merger with US biotech Neuphoria Therapeutics,…
REG - Scancell Holdings - Preliminary Results
("Scancell", the "Company" or the "Group") Preliminary Results for the year ended 30 April 2026 Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com3
-
proactiveinvestors.com2
-
kalkinemedia.com1
-
voxmarkets.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.